The use of Brain Magnetic Resonance Imaging in Multiple Sclerosis

Archives of Neurology

Volumn 51, Issue 5, 1994, Pages 505-516

  Goodkin, Donald E ^a   Rudick, Richard A ^b   Ross, Jeffery S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Neurology Mellen Center for Multiple Sclerosis Treatment and Research ^*  (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

BRAIN; GADOLINIUM DTPA; HUMAN; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0028359210     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1994.00540170087020     Document Type: Article

References (106)

1. Kucharczyk W, Brant-Zawadzki M. Magnetic Resonance Imaging: Basic Principles, Instrumentation and Tissue Characterization. Princeton, NJ: Continuing Professional Center Inc; 1985;6:1-7.
2. Jacobson HG. Fundamentals of magnetic resonance imaging. JAMA. 1987; 258:3417-3423.
3. Young IR, Hall AS, Pallis CA, et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet. 1981;2:1063-1066.
4. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977;33:4-8.
5. Rose AS, Ellison GW, Meyers LW, Tourtellotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology. 1976;26:20-22.
6. Schumacher GA, Beebe GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552-568.
7. Bauer HJ. IMAB-Enquete concerning the diagnostic criteria for MS. In: Bauer HG, Poser S, Ritter G, eds. Progress in Multiple Sclerosis Research. Berlin, Germany: Springer Verlag; 1980:555-563.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
9. Kirshner HS, Tsai SI, Runge VM, Price AC. Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis. Arch Neurol. 1984;42:859-863.
10. Gebarski SS, Gabrielsen TO, Gilman S, et al. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol. 1985; 17:469-474.
11. Uhlenbrock D, Seidel D, Gehlen W, et al. MR imaging in multiple sclerosis: comparison with clinical, CSF, and visual evoked potential findings. AJNR Am J Neuroradiol. 1988;9:59-67.
12. Jacobs L, Kinkel PR, Kinkel WR. Impact of nuclear magnetic resonance imaging on the assessment of multiple sclerosis patients. Semin Neurol. 1986;6:24-32.
13. Scotti G, Scialfa G, Biondi A, Landoni L, Caputo D, Cazzullo CL. Magnetic resonance in multiple sclerosis. Neuroradiology. 1986;28:319-323.
14. Stewart JM, Houser OW, Baker HL, O'Brien PC, Rodriguez M. Magnetic resonance imaging and clinical relationships in multiple sclerosis. Mayo Clin Proc. 1987;62:174-184.
15. Eisen A, Odusote K, Li D, et al. Comparison of magnetic resonance imaging with somatosensory testing in MS suspects. Muscle Nerve. 1987;10:385-390.
16. Honig LS, Siddharthan R, Sheremata WA, Sheldon JJ, Sazant A. Multiple sclerosis: correlation of magnetic resonance imaging with cerebrospinal fluid findings. J Neurol Neurosurg Psychiatry. 1988;51:277-280.
17. Bone G, Ladurner G, Artmann W, Bsteh C. Correlations between clinical and magnetic resonance imaging findings in multiple sclerosis. Eur Neurol. 1988; 28:212-216.
18. Baumhefner RW, Tourtellotte WW, Syndulko K, et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Arch Neurol. 1990; 47:19-26.
19. Baum K, Scheuler W, Hegerl U, Girke W, Schorner W. Detection of brainstem lesions in multiple sclerosis: comparison of brainstem auditory evoked potentials with nuclear magnetic resonance imaging. Acta Neurol Scand. 1988;77: 283-288.
20. Noseworthy JH, Paty KW, Ebers GC. Neuroimaging in multiple sclerosis. Neurol Clin. 1984;2:759-777.
21. Rumbach L, Warter JM, Marescaux C, Gounot D, Chambron J, Collard M. Multiple sclerosis diagnosis. Eur Neurol. 1987;27:92-96.
22. Bogousslavsky J, Fox AJ, Carey LS, et al. Correlates of brain-stem oculomotor disorders in multiple sclerosis. Arch Neurol. 1986;45:460-463.
23. Golden GS, Woody RC. The role of nuclear magnetic resonance imaging in the diagnosis of MS in childhood. Neurology. 1987;37:689-693.
24. Millner MM, Ebner F, Justich E, Urban C. Multiple sclerosis in childhood: contribution of serial MRI to earlier diagnosis. Dev Med Child Neurol. 1990;32:769-777.
25. Haas G, Schroth G, Grageloh-Mann I, Buchwald-Saal M. Magnetic resonance imaging of the brain of children with multiple sclerosis. Dev Med Child Neurol.1987; 29:586-591.
26. National Multiple Sclerosis Society Working Group on Neuroimaging forthe Medical Advisory Board. Use of magnetic resonance imaging in the diagnosis of multiple sclerosis: policy statement. Neurology. 1986;36:1575.
27. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS. Neurology. 1988;38:180-185.
28. Kesselring J, Miller DH, Robb SA, etal. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain. 1990;113:291-302.
29. Miller DH, Johnson G, Tofts PS, et al. Precise relaxation time measurements of normal appearing white matter in inflammatory central nervous system disease. Magn Reson Med. 1989;11:331-336.
30. Ormerod IE, Johnson G, MacManus D, du Boulay EP, McDonald WI. Relaxation times of apparently normal cerebral white matter in multiple sclerosis. Acta Radiol. 1986;369:382-384.
31. Haughton VM, Yetkin ZF, Rao SM, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med. 1992;26:71-78.
32. Kesselring J, Miller DH, MacManus DG, et al. Quantitative magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989;52:14-17.
33. Brainin M, Neuhold A, Reisner T, Maida E, Lang S, Deecke L. Changes within the ‘normal’ cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. J Neurol Neurosurg Psychiatry. 1989;52:1355-1359.
34. Lynch SG, Rose JW, Smoker W, Petajan JH. MRI in familial multiple sclerosis. Neurology. 1990;40:900-903.
35. Uitehaag BM, Polman CH, Valk J, Koetsier JC, Lucas CJ. Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiatry. 1989; 52:1417-1419.
36. Tienari PJ, Salonen O, Wikstrom J, Valanne L, Palo J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry. 1992;55:883-886.
37. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822-1825.
38. Bradley WG Jr, Waluch V, Brant-Zawadzki M, et al. Patchy, periventricular white matter lesions in the elderly. Noninvasive Med Imaging. 1984;1:35-41.
39. Brant-Zawadzki M, Fein G, Van Dyke C, et al. MR imaging of the aging brain: patchy white-matter lesions and dementia. AJNR Am J Neuroradiol. 1985;6:675-682.
40. Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. Stroke. 1986;17:1085-1089.
41. Ormerod IEC, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. Brain. 1987; 110:1579-1616.
42. Smith AS, Meisler DM, Weinstein MA, et al. High-signal periventricular lesions in patients with neurosarcoidosis. AJNR Am J Neuroradiol. 1989;10:485-490.
43. Yetkin FZ, Haughton VM, Papke RA, et al. Multiple sclerosis: specificity of MR for diagnosis. Radiology. 1991;178:447-451.
44. Soges LJ, Cacayorin ED, Petro GR, et al. Migraine: evaluation by MR. AJNR Am J Neuroradiol. 1988;9:425-429.
45. Moody DM, Bell MA, Challa VR. The corpus callosum, a unique white-matter tract: anatomic features that may explain sparing in Binswanger disease and resistance to flow of fluid masses. AJNR Am J Neuroradiol. 1988;9:1051-1059.
46. Berger JR, Quencer R. Reversible myelopathy with pernicious anemia: clinical/MRI observation. Neurology. 1991;41:947-948.
47. Epperson LW, Whitaker JN, Kapila A. Cranial MRI in acute disseminated encephalomyelitis. Neurology. 1988;38:332-333.
48. Miller DH, Ormerod IEC, Gibson A, et al. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology. 1987;29: 226-231.
49. Stewart WA, Hall LD, Berry K, et al. Magnetic resonance imaging (MRI) in multiple sclerosis (MS). Neurology. 1986;36(suppl 1):320. Abstract.
50. Nagara H, Inoue T, Koga T, Kitaguchi T, Tateishi J, Goto I. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci. 1987;81:67-77.
51. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. Stroke. 1986;17:1090-1097.
52. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The long-standing MS lesion. Brain. 1991;114:1271-1280.
53. Newcombe J, Hawkins CP, Henderson CL, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain. 1991;114:1013-1023.
54. Jacobs L, Kinkel WR, Ploachini I, Kinkel RP. Correlations of nuclear magnetic imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology. 1986;36:27-34.
55. Edwards MK, Farlow MR, Stevens JC. Multiple sclerosis: MRI and clinical correlation. AJR Am J Roentgenol. 1986;147:571-574.
56. Truyen L, Gheuens J, Van de Vyver FL, Parizel PM, Peersman GV, Martin JJ. Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol. J Neurol Sci. 1990;96:173-182.
57. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis. BMJ. 1990;300:631-634.
58. Koopmans RA, Li DKB, Grochowski E, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis. Ann Neurol. 1989;25:74-81.
59. Honer WG, Hurwitz T, Li DL, et al. Temporal lobe involvement in multiple sclerosis patients with psychiatric disease. Arch Neurol. 1987;44:187-190.
60. Huber SJ, Paulson GW, Shuttleworth DC, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol. 1987;44:732-736.
61. Rao SM, Leo GJ, Haughton VM, et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology. 1989;39:161-166.
62. Franklin GM, Heatron RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology. 1988;38:1826-1829.
63. Izquierdo G, Campoy F, Mir J, Gonzalez M, Martinez-Parra C. Memory and learning disturbances in multiple sclerosis. Eur J Radiol. 1991;13:220-224.
64. Anzola GP, Bevilacqua L, Cappa SF, et al. Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1990;53:142-145.
65. Callahan MM, Logsdail SJ, Ron MA, Warrington EK. Cognitive impairment in patients with clinically isolated lesions of the type seen in MS: a psychometric and MRI study. Brain. 1989;112:361-374.
66. Mariani C, Farina E, Cappa SF, et al. Neuropsychological assessment in multiple sclerosis. J Neurol. 1991;238:395-400.
67. Farlow MR, Edwards MK, Kolar OJ, et al. Magnetic resonance imaging in multiple sclerosis: analysis of correlations to peripheral blood and spinal fluid abnormalities. Neurology. 1987;37:1527-1530.
68. Oger J, Kastrukoff LF, Li DKB, et al. Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI. Neurology. 1988; 38:1739-1744.
69. Jacobs L, Kinkel PR, Kinkel WR. Silent brain lesions in patients with isolated idiopathic optic neuritis. Arch Neurol. 1986:43:452-455.
70. Ormerod IEC, McDonald WI, du Boulay GH, et al. Disseminated lesions at presentation in patients with optic neuritis. J Neurol Neurosurg Psychiatry. 1986; 49:124-127.
71. Johns K, Lavin P, Elliot JH, Partain CL. Magnetic resonance imaging of the brain in isolated optic neuritis. Arch Ophthalmol. 1986;104:1486-1488.
72. Paty DW, Oger JJF, Kastrukoff LF, etal. MRI in the diagnosis of MS. Neurology. 1988;38:180-185.
73. Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol. 1987;22:714-723.
74. Miller DH, Ormerod IEC, McDonald WI, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry. 1988;51:1569-1571.
75. Jacobs L, Munschauer FE, Kaba SE. Clinical and magnetic resonance imaging in optic neuritis. Neurology. 1991;41:15-19.
76. Miller DH, Ormerod IEC, Rudge P, et al. Early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol. 1989; 26:635-639.
77. Ford B, Tampiere D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology. 1992;42:250-252.
78. Ropper AH, Poskanzer DC. Prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol. 1978;4:51-59.
79. Christiansen P, Frederiksen JL, Henriksen O, Larsson HB. Gd-DPTAenhanced lesions in the brain of patients with acute optic neuritis. Acta Neurol Scand. 1992;85:141-146.
80. Barkoff F, Hommes OR, Scheltens P, Valk J. Quantitative MRI changes in gadolinium-DPTA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology. 1991;41:1219-1222.
81. Burnham JA, White RR, Dreisbach J, Murray RS. The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions. Neurology. 1991; 41:1349-1354.
82. Barkoff F, Frequin STFM, Hommes OR, et al. A correlative triad of gadolinium-DPTA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Neurology. 1992;42:63-67.
83. Issac C, Li DKB, Genton M, et al. Multiple sclerosis. Neurology. 1988;38:1511-1515.
84. Truyen L, Gheuens J, Parizel PM, Van de Vyvey FL, Martin JJ. Long-term follow-up of multiple sclerosis by standardized non-contrast enhanced magnetic resonance imaging. J Neurol Sci. 1991;106:35-40.
85. Ebner F, Millner MM, Justich E. Multiple sclerosis in children: value of serial MR studies to monitor patients. AJNR Am J Neuroradiol. 1990;11:1023-1027.
86. Willoughby EW, Grochowski E, Li DKB, et al. Serial magnetic resonance scanning in multiple sclerosis. Ann Neurol. 1989;25:43-49.
87. Koopmans RA, Li DKB, Oger JJF, et al. Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months. Ann Neurol. 1989;26: 248-256.
88. Goodkin DE, Ross JS, Vanderbrug-Medendorp S, Konecsni J, Rudick RA. MRI lesion enlargement in multiple sclerosis: disease-related activity, chance occurrence, or measurement artifact? Arch Neurol. 1992;49:261-264.
89. Goodkin DE, Vanderbrug-Medendorp S, Ross J. The effect of repositioning error on serial brain MRI scans in MS patients. Arch Neurol. In press.
90. Grossman RI, Gonzalez-Sacrano F, Atlas SW, et al. Gadolinium enhancement in multiple sclerosis. Radiology. 1986;161:721-725.
91. Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol. 1987;21:300-306.
92. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain. 1990;113:1477-1489.
93. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988;111:927-939.
94. Grossman RI, Braffman BH, Brorson JR, et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology. 1988;169:117-122.
95. Bastianello S, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DPTA MRI enhancement in multiple sclerosis. Neurology. 1990;40:591-595.
96. Capra R, Marciano N, Vignolo L, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol. 1992;49:687-689.
97. Thompson AJ, Miller DH, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis of varying disease duration. Neurology. 1992; 42:60-63.
98. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991;29: 53-62.
99. Harris JO, Frank JA, Patronas NJ, McFarlin DE, McFarland HF. Serial gadolinium enhanced magnetic resonance imaging scans in patients with early relapsingremitting multiple sclerosis: implications for clinical trials. Ann Neurol. 1991;29: 1058-1065.
100. Kappos L, Stadt D, Ratzka M, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology. 1988;30:299-302.
101. The Multiple Sclerosis Study Group. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis. Ann Neurol. 1990;27:591-605.
102. Kastrukoff LF, Oger JJ, Hashimoto SA, etal. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. Neurology. 1990;40:479-486.
103. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry. 1991;54:683-688.
104. Kappos L, Gold R, Stadt D, Heun R, Keil W, Radu EW. MS: definite diagnosis at first presentation? Neurology. 1991;41(suppl 1):168.
105. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis. Neurology. 1991;41:657-660.
106. Paty DW, Li DKB, the UBC MS/MRI Study Group, and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, II. Neurology. 1993:43:662-667.